Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
PACB
Showing 8 of 26 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in Pacific Biosciences of California, Inc.
Yes. Farallon Capital Management holds 14,200 shares of PACB (Pacific Biosciences of California), worth $23,856, as of its Q2 2026 13F filing. It reduced the position by 120,800 shares (-89.5%) from Q1 2026. Farallon Capital Management has held PACB since Q4 2022, across 15 quarterly 13F filings.
Current Value
$23,856
Current Shares
14,200
Total Value Change
-$205,644
Total Shares Change
-120,800
Quarter-by-Quarter History